Strategic partnerships FDB’s recent integrations and collaborations, such as Photon Health integration with FDB Vela and the ongoing partnership with NCPDP Foundation, indicate a customer-centric approach to expanding connectivity and interoperability. Target hospitals and health systems prioritizing seamless data exchange and prescribing workflows present opportunities for expanded license use and implementation support.

Cloud native growth The launch of FDB Vela as a cloud-native ePrescribing network signals a push toward scalable, enterprise-grade solutions. Sales opportunities exist with large health networks and ISVs looking to modernize prescribing, decision support, and medication data sharing across ambulatory and inpatient settings.

Clinical efficiency FDB’s focus on drug knowledge to improve patient safety, operational efficiency, and health outcomes aligns with healthcare buyers seeking to reduce medication errors and optimize workflows. Upsell opportunities include expanding MAR integration, clinical decision support modules, and education tooling embedded in electronic systems.

Market validation Awards and significant revenue milestones, including AMIA recognition and a multi-hundred-million revenue range, bolster credibility with prospects. Leverage third-party validation in sales pitches to win contracts with mid-market and enterprise health systems seeking proven vendor partnerships.

Mergers and momentum Notable acquisitions and funding-like activity (historical) plus strategic acquisitions in the ecosystem (e.g., Fiserv context) suggest a robust M&A environment and potential integration opportunities. Approach potential clients with integration-ready capabilities and services that connect with their existing healthcare IT stack.